Complications and the impact of hematological parameters in donors involved in allogenic peripheral blood stem cell transplantation for hematological malignancies
DOI:
https://doi.org/10.34117/bjdv10n5-066Keywords:
hematopoietic stem cell transplantation, Allogeneic, G-CSF, donorAbstract
Hematopoietic stem cell transplantation (HSCT) is a vital treatment option for many hematological malignancies, offering a more convenient alternative to bone marrow transplantation. In allogeneic HSCT, donors provide hematopoietic stem cells for transplantation into patients, necessitating careful consideration of the donor's health and hematological parameters to ensure successful engraftment and treatment outcomes. In a study involving 20 adult donors at Apeksha Hospital, Sri Lanka key hematological parameters, comorbidities, clinical histories, and medications were analyzed. Diabetes mellitus and hypertension were the most prevalent comorbidities among donors, while anemia, primarily linked to iron and vitamin B12 deficiencies, was common. Although baseline coagulation abnormalities were rare and no significant complications occurred during transplantation, early clinical issues such as pain and paresthesia correlated with abnormal peripheral blood smear findings. Notably, a 4-day single daily G-CSF dosing schedule was favored over a 5-day twice daily regimen due to fewer reported problems. While anemia and thrombocytopenia were infrequent, these findings underscore the critical importance of meticulous donor selection and vigilant monitoring throughout the transplantation process to optimize outcomes.
References
AUGUSTSSON, C. (2024). A nonneutralizing antibody as cause of prothrombin deficiency in a patient with follicular lymphoma. Clinical Case Reports, 12(1). https://doi.org/10.1002/ccr3.8400
BATTE, A., MENON, S., SSENKUSU, J., KIGULI, S., KALYESUBULA, R., LUBEGA, J., … & CONROY, A. (2022). Acute kidney injury in hospitalized children with sickle cell anemia. BMC Nephrology, 23(1). https://doi.org/10.1186/s12882-022-02731-9
DEv, P., Singh, V., Kumar, A., Chaurasia, R., Singh, N., Gautam, P., … & Pathak, A. (2022). Use of ceftriaxone as a predictor of good outcome in stroke patients: a retrospective chart review. Annals of Neurosciences, 29(2-3), 116-120. https://doi.org/10.1177/09727531221086736
FINAZZI, G., VANNUCCHI, A., & BARBUI, T. (2018). Prefibrotic myelofibrosis: treatment algorithm 2018. Blood Cancer Journal, 8(11). https://doi.org/10.1038/s41408-018-0142-z
ITOH, S., YOSHIZUMI, T., TOMIYAMA, T., ISEDA, N., MORINAGA, A., SHIMAGAKI, T., … & MORI, M. (2021). Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma. JGH Open, 5(7), 785-792. https://doi.org/10.1002/jgh3.12588
JÚNIOR, J., MARTINHO, G., MACEDO, A., VERÇOSA, M., NOBRE, V., & TEIXEIRA, G. (2019). Assessing the impact of abo incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study. Hematology Transfusion and Cell Therapy, 41(1), 1-6. https://doi.org/10.1016/j.htct.2018.05.007
KONG, Y., CHANG, Y., WANG, Y., CHEN, Y., WANG, H., WANG, Y., … & HUANG, X. (2013). Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 19(10), 1465-1473. https://doi.org/10.1016/j.bbmt.2013.07.014
KOSCHADE, S., STRATMANN, J., MIESBACH, W., STEFFEN, B., FINKELMEIER, F., BRANDTS, C., … & BALLÓ, O. (2021). Intracranial hemorrhage in newly diagnosed non‐promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy. European Journal of Haematology, 108(2), 125-132. https://doi.org/10.1111/ejh.13718
MARTIN, P., LI, S., NIKIFOROW, S., ALYEA, E., ANTIN, J., ARMAND, P., … & SOIFFER, R. (2016). Infused total nucleated cell dose is a better predictor of transplant outcomes than cd34+ cell number in reduced intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation. Haematologica, 101(4), 499-505. https://doi.org/10.3324/haematol.2015.134841
MILLER, J., BINNICKER, M., CAMPBELL, S., CARROLL, K., CHAPIN, K., GILLIGAN, P., … & YAO, J. (2018). A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the infectious diseases society of america and the american society for microbiologya. Clinical Infectious Diseases, 67(6), 813-816. https://doi.org/10.1093/cid/ciy584
MORIN-ZORMAN, S., LOISEAU, P., TAUPIN, J., & CAILLAT‐ZUCMAN, S. (2016). Donor-specific anti-hla antibodies in allogeneic hematopoietic stem cell transplantation. Frontiers in Immunology, 7. https://doi.org/10.3389/fimmu.2016.00307
POZAILOV, S., ELAMOUR, S., NOYMAN, I., & BEN-SHIMOL, S. (2023). Neurologic manifestations of influenza in children. The Pediatric Infectious Disease Journal, 42(6), 461-467. https://doi.org/10.1097/inf.0000000000003874
SCHALET, G., LANGLIE, J., KIM, M., & THALLER, S. (2022). The rule of 10s for cleft repair: a historical review of the literature. Journal of Craniofacial Surgery, 34(3), 884-887. https://doi.org/10.1097/scs.0000000000008994
YR, M., XU, L., XH, Z., CH, Y., WANG, Y., FR, W., … & HUANG, X. (2016). Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation. Bone Marrow Transplantation, 52(3), 409-414. https://doi.org/10.1038/bmt.2016.283
